Lineage Cell Therapeutics, Inc. ( LCTX) - Stock Earnings
LCTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
LCTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 851000 USD | 6.6 million USD |
| 2026Q1 | -4.8 million USD | 1.7 million USD |
| 2026Q2 | 1.5 million USD | 1.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LCTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.5 million USD | 8.9 million USD |
| 2024 | -18.6 million USD | 9.5 million USD |
| 2025 | -63.5 million USD | 14.6 million USD |
| 2026 Est. | — | — |
LCTX
Price: $0.98
Earnings Per Share: -0.19 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 400600
Market Capitalization: 236.2 million